Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of conjunctival, episcleral and scleral thickness in healthy individuals using anterior segment optical coherence tomography.

Acta ophthalmologica·2023
Same author

Subconjunctival Rituximab Administration for the Treatment of Scleritis.

Ocular immunology and inflammation·2022
Same author

Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis.

Ocular immunology and inflammation·2021
Same author

Recurrences of Scleritis after Ocular Surgery.

Ocular immunology and inflammation·2021
Same author

Current insights in the pathogenesis of scleritis.

Experimental eye research·2020
Same author

Integrated omics analysis of sweat reveals an aberrant amino acid metabolism pathway in Vogt-Koyanagi-Harada disease.

Clinical and experimental immunology·2020

Related Experiment Video

Updated: Jul 22, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Uveitis and systemic disease.

A Rothova1, H J Buitenhuis, C Meenken

  • 1Academic Medical Centre, Department of Ophthalmology, Amsterdam, The Netherlands.

The British Journal of Ophthalmology
|March 1, 1992
PubMed
Summary

This study examined 865 patients with uveitis to determine how often the condition is linked to systemic diseases. Using a structured diagnostic approach, researchers found that 73% of patients received a specific diagnosis. Of these, 26% had a definite association with systemic diseases like sarcoidosis or HLA-B27-related conditions. The study also found that many systemic diseases were not suspected before eye involvement. The most common uveitis type was HLA-B27-associated acute anterior uveitis. The findings suggest that a tailored diagnostic protocol can improve diagnostic accuracy and help identify systemic associations in uveitis cases.

Keywords:
Uveitis diagnosisSystemic disease in uveitisClinical diagnostic approachAutoimmune uveitis

Frequently Asked Questions

More Related Videos

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Related Experiment Videos

Last Updated: Jul 22, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Area of Science:

  • Ophthalmology and immunology research
  • Autoimmune disease diagnostics in clinical medicine
  • Systemic disease associations in uveitis studies

Background:

Understanding the link between uveitis and systemic diseases remains a challenge in clinical diagnostics. Prior research has shown that uveitis often occurs alongside autoimmune or inflammatory conditions, but the exact frequency and nature of these associations remain unclear. No prior work had resolved the diagnostic yield of limited laboratory screening in uveitis patients. This gap motivated a study to assess the frequency of systemic disease associations in uveitis cases. It was already known that uveitis can be idiopathic or part of a broader systemic disorder. However, the proportion of uveitis cases with identifiable systemic causes had not been fully quantified. The uncertainty around diagnostic approaches led to the need for a structured diagnostic protocol. This study aimed to clarify the value of a tailored diagnostic strategy in uveitis. By examining a large cohort, the research sought to determine how often systemic diseases co-occur with uveitis.

Purpose Of The Study:

The study aimed to determine the frequency of systemic diseases associated with uveitis and to evaluate the effectiveness of limited laboratory screening. It was already known that uveitis can be idiopathic or part of a broader systemic disorder. However, the proportion of uveitis cases with identifiable systemic causes had not been fully quantified. The uncertainty around diagnostic approaches led to the need for a structured diagnostic protocol. This study aimed to clarify the value of a tailored diagnostic strategy in uveitis. By examining a large cohort, the research sought to determine how often systemic diseases co-occur with uveitis. The specific problem addressed was the lack of standardized diagnostic procedures in uveitis cases. The motivation stemmed from the need to improve diagnostic accuracy and patient outcomes. The study also aimed to identify the most common systemic associations with uveitis.

Main Methods:

The study involved 865 patients with uveitis who underwent a standard diagnostic protocol. The protocol included a thorough history, ophthalmologic examination, and laboratory and radiographic studies. When indicated, additional special tests were performed in order of likelihood, following a tailored approach. The diagnostic process was designed to be efficient and focused on the most probable systemic associations. No prior work had resolved the diagnostic yield of limited laboratory screening in uveitis patients. The study used a prospective design to collect data systematically. The tailored approach ensured that diagnostic resources were used effectively. The methods allowed for the identification of systemic diseases that were not suspected prior to eye involvement.

Main Results:

A specific diagnosis was established for 628 patients (73%) based on the diagnostic protocol. A definite association with systemic disease was determined for 220 patients (26%). A relationship with a subclinical systemic disorder could be presumed in 201 cases (23%). A well-established clinical uveitis entity without a recognizable systemic disorder was present in 207 cases (24%). For 237 patients (27%), a diagnosis could not be determined. The most frequently observed systemic diseases were sarcoidosis (7%) and HLA-B27-associated seronegative spondylarthropathies (6%). Presumed or definite toxoplasmosis was encountered in 10% of cases. HLA-B27-associated acute anterior uveitis was the most common clinical entity (17%).

Conclusions:

The study found that a significant proportion of uveitis cases are associated with systemic diseases. The authors propose that limited laboratory screening can identify these associations in a notable percentage of cases. The findings suggest that a tailored diagnostic approach improves diagnostic accuracy. The researchers propose that systemic diseases are often not suspected before eye involvement. The study supports the use of a structured diagnostic protocol in uveitis. The results indicate that sarcoidosis and HLA-B27-associated conditions are the most common systemic associations. The authors suggest that further research is needed to refine diagnostic strategies. The study highlights the importance of a comprehensive diagnostic approach in uveitis.

The most frequently observed systemic diseases in the study were sarcoidosis (7%) and HLA-B27-associated seronegative spondylarthropathies (6%).

The study used a standard diagnostic protocol followed by special tests performed in order of likelihood, a tailored approach.

A specific diagnosis was established for 628 patients (73%) based on the diagnostic protocol.

A definite association with systemic disease was determined for 220 patients (26%).

HLA-B27-associated acute anterior uveitis was the most common clinical entity (17%).

The authors propose that a tailored diagnostic approach improves diagnostic accuracy in uveitis cases.